GWAS have demonstrated robust links between NAFLD progression and variations in certain genes, including PNPLA3, TM6SF2, MBOAT7, GCKR, and HSD17B13 [53]. The gene discussed is HSD17B13; the disease is metabolic dysfunction-associated steatotic liver disease.